Dr. McGilvray studied medicine at McGill University, graduating in 1993. He entered the General Surgery training program at the University of Toronto that same year. During his residency, he undertook graduate studies in Dr. Ori Rotstein’s laboratory and obtained a PhD in Cell Biology. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After a clinical fellowship in Transplantation and Hepatobiliary Surgery at the Toronto General Hospital, he began his appointment at the University Health Network in 2003. He is currently an Associate Professor in the Department of Surgery at the University of Toronto.
- Diseases of the liver, particularly viral hepatitis
- Transplant immunology
- Hepatic ischemia/reperfusion injury
- Vascular reconstructive techniques for locally advanced liver and pancreas cancer
- Applicability of transplantation to oncology diagnoses
Antioxidant modulation of skin inflammation: preventing inflammatory progression by inhibiting neutrophil influx.
Can J Surg. 1999 Apr;42(2):109-15
J Surg Res. 1998 Dec;80(2):272-9
Murine hepatitis virus strain 3 induces the macrophage prothrombinase fgl-2 through p38 mitogen-activated protein kinase activation.
J Biol Chem. 1998 Nov 27;273(48):32222-9
World J Surg. 1998 Feb;22(2):179-86
Shock. 1997 Dec;8(6):432-8
Arch Surg. 1997 Nov;132(11):1165-9; discussion 1170
The role of tyrosine phosphorylation in lipopolysaccharide- and zymosan-induced procoagulant activity and tissue factor expression in macrophages.
Infect Immun. 1997 Jun;65(6):2362-70
VLA-4 integrin cross-linking on human monocytic THP-1 cells induces tissue factor expression by a mechanism involving mitogen-activated protein kinase.
J Biol Chem. 1997 Apr 11;272(15):10287-94
Arch Surg. 1996 Dec;131(12):1273-8; discussion 1278-9
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Surgery, Faculty of Medicine, University of Toronto